Item 8.01 Other Events.

On January 10, 2023, ProKidney Corp. issued a press release to announce the publication of the trial design and early data analysis from REGEN-003, a Phase 2 clinical study of Renal Autologous Cell Therapy (REACT®), in the Journal of Blood Purification. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibits filed as part of this Current Report on Form 8-K are listed in the index to exhibits immediately preceding the signature page to this Current Report on Form 8-K, which index to exhibits is incorporated herein by reference.



Exhibit No.            Description of Exhibit
99.1            Press Release dated January 10, 2023



104   Cover Page Interactive Data File (embedded within Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses